Enjoy the event with subtitles available in multiple languages. *Subtitles are AI-generated and may contain inaccuracies.
close
This content is not available in your location
This event is scheduled for
Watch the full session for free✓ Free registration✓ No payment required
To access AIS Channel content, please allow all cookies. Please click here to configure your preferences.
Rethinking the Optimal Path for Rectal Cancer: Upfront Surgery and Neoadjuvant Therapy
JAPAN Precise Surgery - JSES
Share
share
Feb, 2026
Chat
keyboard_arrow_down
Description
keyboard_arrow_down
In recent years, the debate between upfront surgery and neoadjuvant therapy has become a cornerstone in the management of rectal cancer. Choosing the optimal path requires a deep understanding of varying international guidelines and the precision offered by modern surgical techniques.
Thanks to the integration of laparoscopic and robotic-assisted systems, surgeons can now achieve higher levels of precision in Local Axial Resection (LAR), adhering to rigorous clinical standards to improve patient quality of life.
Welcome and Introduction - by Dr. Soichiro Ishihara (Japan)
Advanced Lower Rectal Cancer: Clinical Guidelines and Surgical Excellence in Robotic LAR - Dr. Yoshiro Itatani (Japan)
The UK/European Perspective: Guidelines, Strategies, and the Upfront Surgery Debate - Dr. Jim S. Khan (UK)
Precision in Practice: Laparoscopic LAR Following Japanese Guidelines - Dr. Soichiro Ishihara (Japan)
Panel Discussion & Closing Remarks - Moderated by Dr. Soichiro Ishihara (Japan)